Feed LONN.SW
LO

Lonza Group AG LONN.SW SIX · Healthcare · Switzerland

CHF 666.80 +0.57% +CHF 3.80

Market cap
CHF 46.6B
Enterprise value
CHF 50.3B
P/E
41.8x
Forward P/E
35.8x
PEG
1.0x
P/S
6.8x
P/FCF
285.7x
EV/EBITDA
23.4x
ROIC
8.1%
Gross margin
36.6%
Net margin
16.2%
Dividend yield
0.75%
Payout ratio
31.3%
Net debt/EBITDA
1.7x
Beta
0.84
Free float
99.9%

Sector

Healthcare

Industry

Biotechnology

CEO

Wolfgang Wienand

Employees

20,141

Headquarters

Basel

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Earnings per share fell by 6.1% a year over the last 3 years.
  • What to watch: It missed profit estimates 4 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 CHF of revenue, 16 CHF is left as net profit.

Financial health

Can it carry its debt?

  • What speaks for it: It passes 9 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy